# Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain

> **NCT04238676** · PHASE1,PHASE2 · COMPLETED · sponsor: **Persica Pharmaceuticals Ltd** · enrollment: 43 (actual)

## Conditions studied

- Chronic Low-back Pain

## Interventions

- **DRUG:** PP353
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04238676
- **Lead sponsor:** Persica Pharmaceuticals Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-20
- **Primary completion:** 2024-12-09
- **Final completion:** 2024-12-09
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2026-03-27

## Collaborators

- Micron Research Ltd

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04238676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04238676, "Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04238676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*